Fourth Annual Erminio Costa Memorial Lecture *
25Apr
Event Info
Date:Wednesday, April 25, 2018
Time:12:00 PM - 01:00 PM
Speaker:Daniel R. Weinberger MD
Director and CEO, Lieber Institute for Brain Development
Professor, Departments of Psychiatry, Neurology, Neuroscience and The Institute of Genetic Medicine
Johns Hopkins University School of Medicine
Topic:Genomic insights about the developmental origins of schizophrenia
Location:
College of Medicine Research Building
909 S. Wolcott Avenue
Chicago IL 60612
Room #:Moss Auditorium
Map:
Dr. Weinberger is Director and CEO of the Lieber Institute for Brain Development at the Johns Hopkins Medical Center and Professor of Psychiatry, Neurology, Neuroscience and Human Genetics at the Johns Hopkins School of Medicine. He was formally Director of the Genes, Cognition, and Psychosis Program of the Intramural Research Program, National Institute of Mental Health, National Institutes of Health in Bethesda, Maryland. He attended college at the Johns Hopkins University and medical school at the University of Pennsylvanian and did residencies in psychiatry at Harvard Medical School and in neurology at George Washington University. He is board certified in both psychiatry and neurology.
Dr. Weinberger's research has focused on brain mechanisms involved in the pathogenesis and treatment of neuropsychiatric disorders, especially schizophrenia. He was instrumental in focusing research on the role of abnormal brain development as a risk factor for schizophrenia. His has identified a number of specific neural and molecular mechanisms of genetic risk for schizophrenia, and genetic effects that account for variation in specific human cognitive functions and in human temperament. In 2003, Science magazine highlighted the genetic research of his lab as the second biggest scientific breakthrough of the year, second to the origins of the cosmos.
He is the recipient of many honors and awards, including the K.J. Zulch Prize of the Max Planck Society, the NIH Directors Award, The Roche-Nature Medicine Neuroscience Award, The William K. Warren Medical Research Institute Award, the Adolf Meyer Prize of the American Psychiatric Association,, the Foundation's Fund Prize from the American Psychiatric Association, and the Lieber Prize of the National Alliance for Research on Schizophrenia and Affective Disorders. He is past president of the Society of Biological Psychiatry, past President of the American College of Neuropsychopharmacology and has been elected to the National Academy of Medicine of the National Academy of Sciences.
* Will not count for CME/CEU credit